Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment [Phase 3]
Phase 3 trial evaluating long-term interferon for patients with hepatitis C who did not clear the virus with standard treatment; study compl…
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)
A completed clinical trial assessing compliance of genotype 1 hepatitis C patients treated with PegIntron and Rebetol under a patient-assist…
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV) [Phase 2]
Phase 2 clinical trial evaluating interventions to reduce alcohol use in individuals on methadone with hepatitis C; status: completed.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548) [Phase 3]
Phase 3 trial evaluating three regimens of PegIntron (pegylated interferon alfa-2b) plus ribavirin in treatment-naïve adults with chronic he…
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Zidovudine Levels in HIV Infected Patients Being Treated for HCV [Phase 1, Phase 2]
This clinical trial update reports on zidovudine concentration levels in HIV-infected patients treated for hepatitis C in Phase 1 and Phase …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: NIDDM and IR in Combination Therapy for CHC [NA]
Update on a combination therapy trial for chronic hepatitis C focusing on insulin resistance and non-insulin-dependent diabetes mellitus; th…
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)
This is a completed clinical trial (Study P04067) evaluating patient satisfaction in chronic hepatitis C patients treated with PegIntron and…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833) [Phase 3]
Phase 3 trial P03833 evaluating PegIntron (peginterferon alfa-2b) plus Rebetol (ribavirin) in chronic hepatitis C patients who did not respo…
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED) [Phase 4]
A Phase 4 study comparing 48 weeks versus 24 weeks of Peg-Intron with ribavirin in chronic hepatitis C (genotype 3) was terminated; results …
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)
A completed clinical trial evaluating patient satisfaction with PegIntron Pen plus Rebetol in chronic hepatitis C patients.
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685) [Phase 3]
A Phase 3 study evaluating extended treatment with PEG-Intron and Rebetol in genotype 1 chronic hepatitis C patients with slow virologic res…
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State [Phase 1]
Phase 1 bioavailability study of PF-00868554 administered as 3x250 mg tablets (wet granulate), 3x250 mg tablets (dry granulate), and a 750 m…
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) [Phase 2]
This is a Phase 2 clinical trial update reporting the completion of a study evaluating CIFN and interferon gamma-1b, with or without ribavir…
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569) [Phase 3]
Phase 3 trial evaluating Peg-Intron (pegylated interferon alfa-2b) to prevent disease progression in patients with chronic hepatitis C and c…
-
CLINICAL_TRIALS trial_result · 2009-06-02Clinical Trial Update: Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)
Clinical trial update for NCT00705107 reports treatment adherence using PegIntron Pen plus Rebetol in treatment-naïve adults with Hepatitis …
-
CLINICAL_TRIALS trial_result · 2009-06-02Clinical Trial Update: Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301)
This completed clinical trial in Romania evaluated patient satisfaction in hepatitis C patients treated with PegIntron Pen and Rebetol.
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment [NA]
Clinical trial update examining interactions between hepatitis C viral dynamics and immune activation in patients coinfected with HIV during…
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin [Phase 3]
A Phase 3 trial assessed whether paroxetine can prevent depressive syndrome in patients with chronic hepatitis C treated with pegylated inte…
-
CLINICAL_TRIALS trial_result · 2009-05-12Clinical Trial Update: Metabolic Viral Host Properties
A completed clinical trial investigating metabolic viral host properties in Hepatitis C virus infection has concluded.
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin [Phase 1, Phase 2]
An update on Pharmasset's adaptive Phase I/II hepatitis C trial of a nucleoside analogue in combination with interferon and ribavirin.
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: Factors Associated to Success of Hepatitis C Therapy
This completed clinical trial update identifies factors associated with successful outcomes in Hepatitis C therapy. The study was sponsored …
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects [Phase 1]
Pfizer completed a Phase 1 radiolabel ADME study of PF-00868554 in healthy adult male subjects for hepatitis C.
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1) [Phase 3]
A Phase 3 trial evaluating PEG-Intron (pegylated interferon alfa-2b) plus REBETOL (ribavirin) in pediatric patients with chronic hepatitis C…
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance [Phase 2]
A Phase 2 trial evaluating thalidomide with peginterferon and ribavirin in interferon-resistant hepatitis C. The current status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-03-02Clinical Trial Update: A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C [Phase 2]
Phase 2 study evaluating the combination of pegylated interferon alfa and valopicitabine for chronic hepatitis C has completed.